Big Gain For Aeterna Zentaris Inc.
Tue, Feb 02, 2021 at 05:30 PM
Aeterna Zentaris Inc. (AEZS:NASDAQ) rocketted at $1, representing a gain of 42.9%. On Mon 01 Feb 21, AEZS:NASDAQ hit a New 2-Week Intraday Low of $0.66. The stock appeared on our News Catalysts scanner on Tue 02 Feb 21 at 10:04 AM in the 'AGREEMENT' category. From Tue 19 Jan 21, the stock recorded 55.56% Up Days and 20.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Aeterna Zentaris Inc. (AEZS:NASDAQ)
AEterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing novel treatments in oncology, endocrinology and women's health.
Top 10 Gainers:
- Cassava Sciences, Inc. (SAVA:NASDAQ), 141.15%
- Ocugen, Inc. (OCGN:NASDAQ), 80.11%
- HOL (HOL:NASDAQ), 57.09%
- Vaxart, Inc. (VXRT:NASDAQ), 49.84%
- Aeterna Zentaris Inc. (AEZS:NASDAQ), 42.86%
- Lizhi Inc. (LIZI:NASDAQ), 41.37%
- NTN Buzztime, Inc. (NTN:NYSEMKT), 36.91%
- Moleculin Biotech, Inc. (MBRX:NASDAQ), 35.96%
- SELLAS Life Sciences Group, Inc. (SLS:NASDAQ), 34.1%
- The9 Limited (NCTY:NASDAQ), 33.09%